Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
McKinsey
QuintilesIMS
Baxter
Johnson and Johnson
Covington
Accenture
Novartis
Moodys
Dow

Generated: February 21, 2018

DrugPatentWatch Database Preview

Carbidopa - Generic Drug Details

« Back to Dashboard

What are the generic sources for carbidopa and what is the scope of carbidopa patent protection?

Carbidopa
is the generic ingredient in sixteen branded drugs marketed by Alvogen Malta, Amerigen Pharms Ltd, Edenbridge Pharms, Novel Labs Inc, Aton, Sun Pharma Global, Wockhardt Ltd, Orion Pharma, Impax Labs Inc, Abbvie Inc, Accord Hlthcare, Apotex, Impax Labs, Kv Pharm, Mylan, Sun Pharm Inds, Merck Sharp Dohme, Ranbaxy, Ucb Inc, Actavis Elizabeth, Apotex Inc, Idt Australia Ltd, Mayne Pharma, SCS, and Watson Labs, and is included in thirty-six NDAs. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carbidopa. Ten suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for carbidopa

US Patents and Regulatory Information for carbidopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 090324-003 Sep 28, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Kv Pharm CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 076663-001 Jun 24, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-003 Jan 7, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Impax Labs CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 076521-001 May 14, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-001 Jan 7, 2015 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-002 Jan 7, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Mylan CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 075091-001 Sep 30, 1999 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-001 Jan 7, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Idt Australia Ltd CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073587-002 Jun 29, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-004 Jan 7, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for carbidopa

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Cerilliant
Cantor Fitzgerald
QuintilesIMS
Boehringer Ingelheim
Merck
Chinese Patent Office
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot